NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for the prevention of bleeding in patients with congenital hemophilia A or B (Factor VIII or IX deficiency hemophilia)
HAYES, Inc.
Record ID 32009100505
English
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2008
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Blood Coagulation
- Blood Loss, Surgical
- Factor VIIa
- Hemophilia A
- Recombinant Proteins
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.